Here are 13 key notes on spine and orthopedic device companies.
The New Economy Magazine awarded Oxford Performance Materials, the only company with FDA clearance to manufacture 3D polymeric orthopedic implants, among the best three-dimensional healthcare innovations.
Aurora Spine named Joe Bocchino regional vice president of sales for the western United States.
Bacterin International Holdings added David Goodman, MD, to board of directors.
Blue Belt Technologies announced that Jose Bossolo, MD, performed the 500th Navio assisted partial knee replacement surgery, worldwide, at Valley Baptist Medical Center in Brownsville, Texas.
Exactech announced the first implantation of the Alteon Tapered Wedge Femoral Stem by orthopedic surgeon Jeffery Pierson, MD.
Halifax Biomedical started a research study for its spine instability measurement system in collaboration with Horizon Health Network.
Mazor Robotics reported second quarter net loss at $3.7 million on a non-GAAP basis, but company CEO Ori Hadomi was positive about Mazor's development over the past quarter and anticipates growth in the future.
Minimus Spine successfully secured the CE Certificate for its TrioJection System for delivering ozone to a herniated spinal disc.
Spine Pain Management appointed Michael K. Smith as vice president and director of sales and marketing for the Quad Video Halo subsidiary.
StemCells reported more than $12 million in net losses for the second quarter of 2014, significantly higher than the $5.8 million net loss reported last year.
Stryker Director Ronda E. Stryker sold 21,000 shares of the company's stock on the open market last Friday, following huge sales in July as well.
Amsterdam-based Tornier reported $86.9 million in second quarter revenue in 2014, an 11 percent increase over the same period last year.
Zacks Equity Research has decided to maintain its "neutral" recommendation for Zimmer, post the Biomet acquisition.
More articles on devices:
100 things to know about spine device companies in 2Q
NIH awards pedicle screw breech-preventing instrument 1st place in undergraduate competition
StemCells suffers $12M net loss in 2Q preparing spinal injury trial: 5 points